A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer
| Image |  |
|---|---|
| Description | scientific article published on 17 December 2014 |
| Author/s |
author: Yu Zong Chen |
| Publication date | December 17, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |